Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53

Carlos E. Irarrázabal; Claudio Rojas; Rosa Aracena; Carola Márquez; Lionel Gil

doi:10.1016/S0378-4274(02)00336-3

Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53

Carlos E. Irarrázabal, Claudio Rojas, Rosa Aracena, Carola Márquez, Lionel Gil^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Abstract

The p53 gene has a polymorphism at codon 72 that presents the arginine or proline genotype, although this polymorphism has been associated with genetically determined susceptibility to lung cancers, the literature has not been consistent with this association. In Chile lung cancer represents the second cause of mortality from cancer. p53 codon 72 polymorphism frequency was studied in a Chilean subpopulation of 133 healthy controls and 111 lung cancer patients. The allelic distribution of the three genotypes (ArgArg, ArgPro, ProPro) in healthy normal controls was 41, 44 and 15%, respectively, which differs slightly from that of lung cancer patients, which was 38, 40 and 22%. A relation between the presence of the Pro allele and lung cancer risk in male smokers was observed. Relative risks were O.R.=2.47 (95% CI: 1.34-4.54) for one single nucleotide polymorphic allele (Pro) and O.R.=3.88 (95% CI: 1.16-13.39) for ProPro genotype.

Original language	English
Pages (from-to)	69-76
Number of pages	8
Journal	Toxicology Letters
Volume	144
Issue number	1
DOIs	https://doi.org/10.1016/S0378-4274(02)00336-3
State	Published - 15 Sep 2003
Externally published	Yes

Bibliographical note

Funding Information:
This research was financed by FONDECYT grants, numbers 2990019 and 1000628 and by European Community INCO project Number 972631. We thank Dr Alvaro Undurraga from the ‘Hospital del Tórax’ for his collaboration in obtaining blood samples from patients. This work has been carried out in accordance with the Chilean Biosafety and Ethical Scientific Research Regulations.

Keywords

Lung cancer risk
PCR-RFLP
Polymorphism
p53 codon 72

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0378-4274(02)00336-3

Cite this

@article{e66dc846f7a543f8b530cf0256a761e5,

title = "Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53",

abstract = "The p53 gene has a polymorphism at codon 72 that presents the arginine or proline genotype, although this polymorphism has been associated with genetically determined susceptibility to lung cancers, the literature has not been consistent with this association. In Chile lung cancer represents the second cause of mortality from cancer. p53 codon 72 polymorphism frequency was studied in a Chilean subpopulation of 133 healthy controls and 111 lung cancer patients. The allelic distribution of the three genotypes (ArgArg, ArgPro, ProPro) in healthy normal controls was 41, 44 and 15%, respectively, which differs slightly from that of lung cancer patients, which was 38, 40 and 22%. A relation between the presence of the Pro allele and lung cancer risk in male smokers was observed. Relative risks were O.R.=2.47 (95% CI: 1.34-4.54) for one single nucleotide polymorphic allele (Pro) and O.R.=3.88 (95% CI: 1.16-13.39) for ProPro genotype.",

keywords = "Lung cancer risk, PCR-RFLP, Polymorphism, p53 codon 72",

author = "Irarr{\'a}zabal, {Carlos E.} and Claudio Rojas and Rosa Aracena and Carola M{\'a}rquez and Lionel Gil",

note = "Funding Information: This research was financed by FONDECYT grants, numbers 2990019 and 1000628 and by European Community INCO project Number 972631. We thank Dr Alvaro Undurraga from the {\textquoteleft}Hospital del T{\'o}rax{\textquoteright} for his collaboration in obtaining blood samples from patients. This work has been carried out in accordance with the Chilean Biosafety and Ethical Scientific Research Regulations.",

year = "2003",

month = sep,

day = "15",

doi = "10.1016/S0378-4274(02)00336-3",

language = "English",

volume = "144",

pages = "69--76",

journal = "Toxicology Letters",

issn = "0378-4274",

publisher = "Elsevier BV",

number = "1",

}

TY - JOUR

T1 - Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53

AU - Irarrázabal, Carlos E.

AU - Rojas, Claudio

AU - Aracena, Rosa

AU - Márquez, Carola

AU - Gil, Lionel

N1 - Funding Information: This research was financed by FONDECYT grants, numbers 2990019 and 1000628 and by European Community INCO project Number 972631. We thank Dr Alvaro Undurraga from the ‘Hospital del Tórax’ for his collaboration in obtaining blood samples from patients. This work has been carried out in accordance with the Chilean Biosafety and Ethical Scientific Research Regulations.

PY - 2003/9/15

Y1 - 2003/9/15

N2 - The p53 gene has a polymorphism at codon 72 that presents the arginine or proline genotype, although this polymorphism has been associated with genetically determined susceptibility to lung cancers, the literature has not been consistent with this association. In Chile lung cancer represents the second cause of mortality from cancer. p53 codon 72 polymorphism frequency was studied in a Chilean subpopulation of 133 healthy controls and 111 lung cancer patients. The allelic distribution of the three genotypes (ArgArg, ArgPro, ProPro) in healthy normal controls was 41, 44 and 15%, respectively, which differs slightly from that of lung cancer patients, which was 38, 40 and 22%. A relation between the presence of the Pro allele and lung cancer risk in male smokers was observed. Relative risks were O.R.=2.47 (95% CI: 1.34-4.54) for one single nucleotide polymorphic allele (Pro) and O.R.=3.88 (95% CI: 1.16-13.39) for ProPro genotype.

AB - The p53 gene has a polymorphism at codon 72 that presents the arginine or proline genotype, although this polymorphism has been associated with genetically determined susceptibility to lung cancers, the literature has not been consistent with this association. In Chile lung cancer represents the second cause of mortality from cancer. p53 codon 72 polymorphism frequency was studied in a Chilean subpopulation of 133 healthy controls and 111 lung cancer patients. The allelic distribution of the three genotypes (ArgArg, ArgPro, ProPro) in healthy normal controls was 41, 44 and 15%, respectively, which differs slightly from that of lung cancer patients, which was 38, 40 and 22%. A relation between the presence of the Pro allele and lung cancer risk in male smokers was observed. Relative risks were O.R.=2.47 (95% CI: 1.34-4.54) for one single nucleotide polymorphic allele (Pro) and O.R.=3.88 (95% CI: 1.16-13.39) for ProPro genotype.

KW - Lung cancer risk

KW - PCR-RFLP

KW - Polymorphism

KW - p53 codon 72

UR - http://www.scopus.com/inward/record.url?scp=0041659122&partnerID=8YFLogxK

U2 - 10.1016/S0378-4274(02)00336-3

DO - 10.1016/S0378-4274(02)00336-3

M3 - Article

C2 - 12919725

AN - SCOPUS:0041659122

SN - 0378-4274

VL - 144

SP - 69

EP - 76

JO - Toxicology Letters

JF - Toxicology Letters

IS - 1

ER -

Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this